Sundaram Multi Pap Ltd is Rated Strong Sell

Feb 21 2026 10:10 AM IST
share
Share Via
Sundaram Multi Pap Ltd is rated Strong Sell by MarketsMojo, with this rating last updated on 21 October 2024. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 February 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Sundaram Multi Pap Ltd is Rated Strong Sell

Understanding the Current Rating

The Strong Sell rating assigned to Sundaram Multi Pap Ltd indicates a cautious stance for investors, suggesting that the stock is expected to underperform relative to the broader market and its peers. This rating is derived from a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. Each of these factors contributes to the overall assessment of the stock’s investment potential.

Quality Assessment

As of 21 February 2026, Sundaram Multi Pap Ltd’s quality grade remains below average. The company exhibits weak long-term fundamental strength, with an average Return on Capital Employed (ROCE) of just 1.94%. This low ROCE suggests that the company is generating limited returns on the capital invested in its operations, which is a concern for long-term value creation. Furthermore, operating profit growth over the past five years has been modest, at an annual rate of 13.96%, indicating restrained expansion in core profitability.

Another critical quality metric is the company’s ability to service its debt. The average EBIT to interest ratio stands at a weak 0.40, signalling that earnings before interest and taxes are insufficient to comfortably cover interest expenses. This financial strain raises concerns about the company’s solvency and operational resilience in challenging market conditions.

Valuation Considerations

Currently, Sundaram Multi Pap Ltd is classified as risky from a valuation standpoint. The stock trades at valuations that are considered unfavourable compared to its historical averages. Despite this, the company’s profits have shown a remarkable increase of 146.9% over the past year, which might appear encouraging at first glance. However, this profit surge has not translated into positive stock returns; the stock has delivered a negative return of -22.12% over the same period.

The Price/Earnings to Growth (PEG) ratio stands at 0.7, which typically suggests undervaluation relative to earnings growth. Yet, the disconnect between rising profits and declining share price points to underlying risks or market scepticism about the sustainability of these earnings improvements. Investors should be wary of this divergence when considering valuation metrics.

Financial Trend Analysis

The financial trend for Sundaram Multi Pap Ltd presents a mixed picture. While the financial grade is very positive, reflecting recent improvements in profitability, the overall trend is overshadowed by weak fundamentals and valuation concerns. The company’s operating profits have turned positive, which is a favourable development, but this has not been sufficient to reverse the stock’s downward trajectory.

Over the last three years, the stock has consistently underperformed the BSE500 benchmark, reinforcing the notion that the company has struggled to deliver competitive returns to shareholders. The negative returns across multiple time frames—1 day (-1.22%), 1 week (-3.57%), 1 month (-1.82%), 3 months (-14.29%), 6 months (-19.80%), year-to-date (-10.00%), and 1 year (-22.12%)—highlight persistent challenges in regaining investor confidence.

Technical Outlook

The technical grade for Sundaram Multi Pap Ltd is bearish, reflecting negative momentum in the stock price and weak market sentiment. The consistent decline in share price over recent months suggests that technical indicators are signalling caution. This bearish trend aligns with the fundamental and valuation concerns, reinforcing the rationale behind the Strong Sell rating.

What This Rating Means for Investors

For investors, the Strong Sell rating serves as a warning to exercise prudence. It suggests that Sundaram Multi Pap Ltd currently faces significant headwinds that could limit capital appreciation and increase downside risk. The combination of below-average quality, risky valuation, mixed financial trends, and bearish technical signals indicates that the stock may not be suitable for risk-averse investors or those seeking stable growth.

Investors should carefully consider their portfolio allocation and risk tolerance before engaging with this stock. Monitoring the company’s financial health and market developments will be essential to reassess the investment thesis as new data emerges.

Just announced: This Small Cap from Tyres & Allied with precise target price is our pick for the week. Get the pre-market insights that informed this selection!

  • - Just announced pick
  • - Pre-market insights shared
  • - Tyres & Allied weekly focus

Get Pre-Market Insights →

Summary of Key Metrics as of 21 February 2026

The company’s microcap status and sector classification as miscellaneous add to the complexity of its investment profile. The Mojo Score currently stands at 23.0, reflecting the Strong Sell grade, down from a previous score of 31 when it was rated Sell on 21 October 2024. This decline in score underscores the deteriorating outlook.

Stock returns over various periods remain negative, with the most recent daily change at -1.22%. The persistent underperformance relative to benchmarks and peers highlights the challenges Sundaram Multi Pap Ltd faces in regaining market favour.

Investors should weigh these factors carefully and consider alternative opportunities with stronger fundamentals and more favourable technical setups.

Conclusion

Sundaram Multi Pap Ltd’s current Strong Sell rating by MarketsMOJO reflects a comprehensive assessment of its quality, valuation, financial trends, and technical outlook as of 21 February 2026. While the company has shown some positive financial developments, significant risks remain, particularly in terms of long-term fundamental strength and market sentiment. This rating advises investors to approach the stock with caution and to prioritise risk management in their investment decisions.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Are Sundaram Multi Pap Ltd latest results good or bad?
Feb 14 2026 07:43 PM IST
share
Share Via
Sundaram Multi Pap Ltd is Rated Strong Sell
Feb 10 2026 10:10 AM IST
share
Share Via
Why is Sundaram Multi Pap Ltd falling/rising?
Feb 05 2026 12:52 AM IST
share
Share Via
Sundaram Multi Pap Ltd is Rated Strong Sell
Jan 30 2026 10:11 AM IST
share
Share Via
Sundaram Multi Pap Ltd is Rated Strong Sell
Jan 19 2026 10:10 AM IST
share
Share Via
Sundaram Multi Pap Ltd is Rated Strong Sell
Jan 06 2026 10:11 AM IST
share
Share Via